Brief: Galera Therapeutics Q2 EPS USD -0.48
14/08/2023 14:22
Aug 14 (Reuters) - Galera Therapeutics Q2 net income USD -20.712 million. * Q2 income from operations USD -16.807 million * Q2 cash & investments USD 38.8 million * Q2 EPS USD -0.48
Recent news on Galera Therapeutics
See all newsBrief: Galera Therapeutics Says Nasdaq Will Delist Co's Common Stock By Filing Form 25 With SEC On Sept 4
Brief: Galera Announces Board Approval Of Complete Liquidation And Dissolution
Brief: Galera Therapeutics Receives Written Notice From Nasdaq Indicating That Nasdaq Hearings Panel Determined To Delist Co’s Shares
Brief: Alpha Pharma Investments Llc Reports 10.899% Passive Stake In Galera Therapeutics
Brief: Galera Adopts Limited Duration Stockholder Rights Agreement